| Target Price | $3.57 |
| Price | $3.74 |
| Deviation |
4.55%
register free of charge
|
| Number of Estimates | 8 |
|
8 Analysts have issued a price target Fulcrum Therapeutics Inc 2027 .
The average Fulcrum Therapeutics Inc target price is $3.57.
This is
4.55%
register free of charge
$25.20
573.80%
register free of charge
$3.03
18.98%
register free of charge
|
|
| A rating was issued by 11 analysts: 0 Analysts recommend Fulcrum Therapeutics Inc to buy, 7 to hold and 4 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Fulcrum Therapeutics Inc stock has an average upside potential 2027 of
4.55%
register free of charge
|
| Analyst | Rating | Action | Date |
|---|---|---|---|
| JP Morgan |
Locked
➜
Locked
|
Locked | Jun 03 2026 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Jun 02 2026 |
| Leerink Partners |
Locked
➜
Locked
|
Locked | Jun 02 2026 |
| Truist Securities |
Locked
➜
Locked
|
Locked | Jun 02 2026 |
| Piper Sandler |
Locked
➜
Locked
|
Locked | Jun 02 2026 |
| Stifel |
Locked
➜
Locked
|
Locked | Jun 02 2026 |
| JP Morgan |
Locked
➜
Locked
|
Locked | Jan 12 2026 |
| Analyst Rating | Date |
|---|---|
|
Locked
JP Morgan:
Locked
➜
Locked
|
Jun 03 2026 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Jun 02 2026 |
|
Locked
Leerink Partners:
Locked
➜
Locked
|
Jun 02 2026 |
|
Locked
Truist Securities:
Locked
➜
Locked
|
Jun 02 2026 |
|
Locked
Piper Sandler:
Locked
➜
Locked
|
Jun 02 2026 |
|
Locked
Stifel:
Locked
➜
Locked
|
Jun 02 2026 |
|
Locked
JP Morgan:
Locked
➜
Locked
|
Jan 12 2026 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


